Andreas Kogelnik, OMI- Clinical Trials in the Age of Social Media
Andy Kogelnik, M.D., Ph.D., Founder & Director, Open Medicine Institute (OMI)
Dr. Kogelnik will discuss how personalization through Genomics, Data Sharing and Social/Mobile technologies is changing all aspects of clinical trials and indeed the way we do research. How do we balance the potential power of crowd sourced data with the rigor of the randomized, controlled trial. New methods for patient engagement and data collection are challenging the traditional paradigms in favor of large scale data collection. These issues are affecting study design, recruitment, regulatory oversight, operations and research methodology. He will highlight several successful studies that have leveraged these technologies.
For more information go to PMWCintl.com
Видео Andreas Kogelnik, OMI- Clinical Trials in the Age of Social Media канала PMWCintl
Dr. Kogelnik will discuss how personalization through Genomics, Data Sharing and Social/Mobile technologies is changing all aspects of clinical trials and indeed the way we do research. How do we balance the potential power of crowd sourced data with the rigor of the randomized, controlled trial. New methods for patient engagement and data collection are challenging the traditional paradigms in favor of large scale data collection. These issues are affecting study design, recruitment, regulatory oversight, operations and research methodology. He will highlight several successful studies that have leveraged these technologies.
For more information go to PMWCintl.com
Видео Andreas Kogelnik, OMI- Clinical Trials in the Age of Social Media канала PMWCintl
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Bill Dalton Smarter Clinical Trials
Ilan Kirsch, Adaptive Biotech: Immunosequencing in the Service of Immunotherapy
Pravene Nath, M.D., MSE, CIO, Stanford Health Care
Neil Barth, Agendia: Molecular Subtypes in Breast Cancer Challenging the Clinical Subtyping Paradigm
Mark Erlander, Trovagene- Quantitative Detection of Cancer Mutations in Liquid Biopsy Samples
Regulatory Framework for Personalized Rx Development: Mike Pacanowski, PMWC 2014 Silicon Valley
Ten Years into Personalize Medicine What We've Learned & What's Next HD
Cliff Reid Whole Genome Sequencing for Diagnosing Intellectual Disability HD
Alexis Borisy: Personalized Medicine Here and Now
Mike Pellini at PMWC 2012
Feng Zhang Broad Institute Acceptance Speech
Amit Etkin, Stanford University: Cogn and Emotional Tests Predicts Treatment Response in Depression
Sharon Terry Speaking @ PMWC 2012
Rachid Karam, Ambry Genetics- Utiliz of NGS Multi Gene Panel Testing in Hereditary Cancer Dx
Panel Genomic Profiling Moving Into Routine Clinical Care
Personalized Medicine Patent Law Update
Alan Schatzberg, Stanford University: Genetics Cognition Blood brain barrier Funct and Drug Selec
John Ryals Metabolon's CEO: Metabolomics as a First Line Phenotyping Tool
Allen Roses, Barbaresco Pharma, Inc.: GWAS Method for Highly Informative Assoc in Complex Diseases
Biomarkers in Depression, Anxiety and ADHD (Brain Resource by Dr. Evian Gordon)